Treatment of obstructive sleep apnoea–hypopnea syndrome by mandible advanced device reduced neuron apoptosis in frontal cortex of rabbits
- 23 September 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Orthodontics
- Vol. 40 (3) , 273-280
Abstract
To investigate effects of mandible advanced device (MAD) therapy for obstructive sleep apnoea–hypopnea syndrome (OSAHS) on the neuron apoptosis and acetylcholine esterase activity in frontal cortex. Thirty male New Zealand white rabbits were randomly divided into three groups (n = 10 in each group): group OSAHS, group MAD, and control group. Hydrophilic polyacrylamide gel was injected into soft palate of the animals to induce OSAHS in group OSAHS and group MAD. The group MAD animals wore MAD to relief the obstructiveness. The control group was not given any treatment. Computed tomography (CT) examination of the upper airway and polysomnography (PSG) recordings were performed in supine position. All rabbits were induced to sleep in a supine position for 4 to 6 hours every day and were observed for consecutive 8 weeks. The frontal cortices of three groups were dissected and the neuron apoptosis was detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) and flow cytometry. Acetylcholine esterase (AchE) activity in the frontal cortex was measured by spectrophotometry. The group OSAHS exhibited high neuron apoptosis rate and low AchE activity than those of group MAD and control group. The blood oxygen saturation was negatively correlated with neuronal apoptosis rate and positively correlated with AchE activity. Applying MAD in OSAHS animals significantly improve the neuronal damage and function deficits by apnoea–hypoxia caused by narrowed upper airway. This study provided evidence that MAD therapy for OSAHS can significantly decrease neuronal apoptosis and increase AchE activity in the frontal cortex.Keywords
This publication has 43 references indexed in Scilit:
- Executive Dysfunction in OSA Before and After Treatment: A Meta-AnalysisSLEEP, 2013
- Effects of Continuous Positive Airway Pressure on Neurocognitive Function in Obstructive Sleep Apnea Patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES)SLEEP, 2012
- Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brainBMC Complementary and Alternative Medicine, 2012
- Apnea produces neuronal degeneration in the pons and medulla of guinea pigsNeurobiology of Disease, 2010
- Executive function in patients with obstructive sleep apnea treated with continuous positive airway pressureJournal of the International Neuropsychological Society, 2010
- Recurrent apnea induces neuronal apoptosis in the guinea pig forebrainExperimental Neurology, 2009
- Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's diseaseBrain Research, 2009
- Central nicotinic cholinergic systems: A role in the cognitive dysfunction in Attention-Deficit/Hyperactivity Disorder?Behavioural Brain Research, 2006
- Frontal brain lobe impairment in obstructive sleep apnoea: a proton MR spectroscopy studyEuropean Respiratory Journal, 2004
- Are oral appliances a substitute for nasal positive airway pressure?Thorax, 2002